0001181431-13-030075.txt : 20130523
0001181431-13-030075.hdr.sgml : 20130523
20130523143647
ACCESSION NUMBER: 0001181431-13-030075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130522
FILED AS OF DATE: 20130523
DATE AS OF CHANGE: 20130523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FERRARI LOUIS
CENTRAL INDEX KEY: 0001513697
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15313
FILM NUMBER: 13867843
MAIL ADDRESS:
STREET 1: 765 WARREN STREET
CITY: WARRREN STREET
STATE: NJ
ZIP: 07090
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd380988.xml
FERRARI FORM 4
X0306
4
2013-05-22
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001513697
FERRARI LOUIS
SAVIENT PHARMACEUTICALS, INC.
400 CROSSING BLVD.
BRIDGEWATER
NJ
08807
1
1
0
0
President and CEO
Common Stock
2013-05-22
4
S
0
1020
0.57
D
307439
D
These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 21, 2011.
Philip K. Yachmetz as attorney-in-fact for Louis Ferrari
2013-05-23